Literature DB >> 16289718

Pre-operative chemo-radiotherapy improves the sphincter preservation rate in patients with rectal cancer located within 3 cm of the anal verge.

D-W Kim1, S-B Lim, D Y Kim, T H Kim, K H Jung, D H Kim, H J Chang, D K Sohn, C W Hong, H S Choi, S-Y Jeong, J-G Park.   

Abstract

AIMS: To evaluate whether pre-operative chemo-radiotherapy (CRT) improves the sphincter preservation rate for distal rectal cancers within 3 cm of the anal verge.
METHODS: Between January 2001 and December 2004, 49 patients underwent surgery with or without pre-operative CRT for primary rectal adenocarcinoma within 3 cm of the anal verge. Clinical data were retrospectively reviewed, including stage workups, surgical records and pathology records to determine sphincter preservation rate and the factors influencing sphincter preservation.
RESULTS: Of 49 patients with rectal tumours within 3 cm of the anal verge, 31 underwent pre-operative CRT followed by surgery (CRT group), and 18 underwent surgery alone (non-CRT group). Sphincter preservation was possible in 11 of 31 CRT patients, and only one of 18 non-CRT patients (p=0.036). The factors most influencing sphincter preservation were reduction in tumour size (p=0.005) and downstaging (p=0.001) following pre-operative CRT.
CONCLUSION: We could observe that sphincter preservation was improved in CRT group with statistical significance when compared to non-CRT group in our study patients with rectal cancer within 3 cm of the anal verge.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16289718     DOI: 10.1016/j.ejso.2005.10.002

Source DB:  PubMed          Journal:  Eur J Surg Oncol        ISSN: 0748-7983            Impact factor:   4.424


  17 in total

1.  Local treatment for rectal cancer.

Authors:  Daniel P Geisler
Journal:  Clin Colon Rectal Surg       Date:  2007-08

Review 2.  Interval to surgery after neoadjuvant treatment for colorectal cancer.

Authors:  Nir Wasserberg
Journal:  World J Gastroenterol       Date:  2014-04-21       Impact factor: 5.742

3.  Predictive value of (18)FDG PET-CT for tumour response in patients with locally advanced rectal cancer treated by preoperative chemoradiotherapy.

Authors:  Jong Wan Kim; Hyun Chul Kim; Ji Won Park; Sung Chan Park; Dae Kyung Sohn; Hyo Seong Choi; Dae Yong Kim; Hee Jin Chang; Ji Yeon Baek; Sun Young Kim; Seok Ki Kim; Jae Hwan Oh
Journal:  Int J Colorectal Dis       Date:  2013-02-13       Impact factor: 2.571

4.  Prognostic value of Smac expression in rectal cancer patients treated with neoadjuvant therapy.

Authors:  Hongjiang Yan; Jinming Yu; Renben Wang; Shumei Jiang; Kunli Zhu; Dianbin Mu; Zhongfa Xu
Journal:  Med Oncol       Date:  2011-01-25       Impact factor: 3.064

5.  Low-lying rectal cancer with anal canal involvement: abdominoperineal or low anterior resection after neoadjuvant chemoradiotherapy.

Authors:  Ly Do; Nisar Syed; Ajmel Puthawala; Samar Azawi; Imad Shbeeb; I-Yeh Gong
Journal:  Gastrointest Cancer Res       Date:  2011-05

6.  Sphincter-preserving surgery after preoperative radiochemotherapy for T3 low rectal cancers.

Authors:  Xue Bai; Shiyong Li; Bo Yu; Hong Su; Weisen Jin; Gang Chen; Junfeng DU; Fuyi Zuo
Journal:  Oncol Lett       Date:  2012-03-26       Impact factor: 2.967

7.  The CARTS study: Chemoradiation therapy for rectal cancer in the distal rectum followed by organ-sparing transanal endoscopic microsurgery.

Authors:  Guus M J Bökkerink; Eelco J R de Graaf; Cornelis J A Punt; Iris D Nagtegaal; Heidi Rütten; Joost J M E Nuyttens; Esther van Meerten; Pascal G Doornebosch; Pieter J Tanis; Eric J Derksen; Roy S Dwarkasing; Corrie A M Marijnen; Annemieke Cats; Rob A E M Tollenaar; Ignace H J T de Hingh; Harm J T Rutten; George P van der Schelling; Albert J Ten Tije; Jeroen W A Leijtens; Guido Lammering; Geerard L Beets; Theo J Aufenacker; Apollo Pronk; Eric R Manusama; Christiaan Hoff; Andreas J A Bremers; Cornelelis Verhoef; Johannes H W de Wilt
Journal:  BMC Surg       Date:  2011-12-15       Impact factor: 2.102

8.  Predictive value of Smac, VEGF and Ki-67 in rectal cancer treated with neoadjuvant therapy.

Authors:  Hongjiang Yan; Renben Wang; Jinming Yu; Shumei Jiang; Kunli Zhu; Dianbin Mu; Zhongfa Xu
Journal:  Oncol Lett       Date:  2010-07-01       Impact factor: 2.967

9.  Influence of anemia on tumor response to preoperative chemoradiotherapy for locally advanced rectal cancer.

Authors:  Seong Dae Lee; Ji Won Park; Kui Seon Park; Seok-Byung Lim; Hee Jin Chang; Dae Yong Kim; Seung-Yong Jeong; Hyo Seong Choi; Jae Hwan Oh
Journal:  Int J Colorectal Dis       Date:  2009-07-07       Impact factor: 2.571

10.  Analysis of anal sphincter preservation rate according to tumor level and neoadjuvant chemoradiotherapy in rectal cancer patients.

Authors:  Seung Hyuk Baik; Nam Kyu Kim; Kang Young Lee; Seung Kook Sohn; Chang Hwan Cho
Journal:  J Gastrointest Surg       Date:  2007-08-13       Impact factor: 3.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.